renouned-medical-scientist-dr-rongxiang-xu-sues-dr-shinya-yamanaka-one-of-the-winners-of-the-2012-nobel-prize-in-physiology-or-medicine-in-the-superior-court-of-california-county-of-san-francisco-us

Stem cell scientist sues Nobel laureate for deception

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Dr Rongxiang Xu, a scientist who claims to be the founder of human body regenerative restoration science, has filed a lawsuit against Dr Shinya Yamanaka,... Read more

mitsubishi-electric-s-proton-therapy-system-reduces-irradiation-time-during-cancer-radiotherapy-to-one-fourth-of-the-current-level

Mitsubishi system reduces radiotherapy time to 1/4

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mitsubishi Electric has completed the construction of a new proton therapy system for cancer treatment at its Energy Systems Center in Kobe, Hyogo Prefecture,... Read more

mr-tatsuya-kimura-drug-information-association-japan

Tatsuya Kimura: Japan is a steadily growing market

  • Japan
  • |
  • Opinion
  • |
  • By Mr Tatsuya Kimura
  • |
  • 0 Comment

The Asian business strategy of multinational pharmaceutical companies in terms of resource reallocation and investment will become a key issue for future growth... Read more

frost-sullivan-partner-ms-reenita-das-says-that-personalization-communication-decentralization-and-collaboration-are-the-new-mantra-in-healthcare

F&S: Personalization is the new mantra in healthcare

  • Japan
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Frost & Sullivan partner Ms Reenita Das during her keynote presentation at the 12th International BIOtech Exhibition and Conference in Tokyo, revealed... Read more

farewell-ms-anna-protopapas-executive-vp-of-bd-takeda-will-replace-millennium-pharma-s-outgoing-ceo-ms-deborah-dunsire

CEO of Takeda's Millennium Pharma quits abruptly

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence of Millennium Pharma... Read more

australian-cellmid-acquires-japanese-advangen

Australian Cellmid acquires Japanese Advangen

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Takeda to acquire Inviragen for $250 mn

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million, and future payments of up to $215 million,... Read more

japan-based-irom-holdings-will-acquire-18

Japanese I’rom acquires 18% in Australian IDT

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading... Read more

takeda-disagrees-with-jury-s-decision-to-give-jack-cooper-and-other-plaintiffs-usd6

Takeda asks judge to rule in its favor

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Takeda Pharmaceuticals, US, highlighted that in the case against Jack Cooper (No CGC-12-518535) the jury ruled in favor of the plaintiffs and awarded... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X